Dear friends of MVMD. I hope this message finds you well and that you and your family are enjoying this amazing summer we are having.
As many of you know from our last few business updates, MVMD has crossed an exciting milestone as we transition from an R&D-focused biotech start-up business into a commercially focused biotech entity.
The team has been working hard on our three core lines of business, which include novel innovations that improve the administration and efficacy of nutraceutical health and wellness products, an agricultural plant signaling technology that organically drives increases in crop yields and supports the reduction of fertilizer usage, and the application of solubilized drugs to positively impact the health of husbandry animals and aquatic species.
Today we sent out a media release providing a complete overview of where we are at and the amazing progress the team has been making across the entire business. You can find the new media release here.
Enjoy the read and as always, please reach out if you have any questions – info@mvmd.com
A few highlights from the media release:
NUTRACEUTICALS
AGRICULTURE
HUSBANDRY ANIMALS / AQUATIC SPECIES
As you can see, the MVMD team and our extensive network of partners has been making great progress on our commercialization objectives. I remain very proud of the progress our team has made as we continue to focus on positive outcomes to impact human, plant and animal health.
Regards,
Dennis Hancock
President & CEO, Mountain Valley MD